Company page

Mineralys Therapeutics, Inc.

Mineralys Therapeutics, Inc. is a public company traded under the ticker MLYS in the American market. The company has a market capitalization of approximately $2.35 billion. Mineralys focuses on developing innovative therapies to address unmet medical needs.

MLYS:NASDAQUpdated August 28, 2026
Mineralys Therapeutics, Inc. logo
Ticker
MLYS:NASDAQ
Asset type
Stock
Market cap
$2.26B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD